ALNY - ALNYLAM PHARMACEUTICALS, INC.


320.66
0.150   0.047%

Share volume: 983,222
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%

$320.51
0.15
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-02-2024 08-01-2024 10-31-2024 02-13-2025 05-01-2025 07-31-2025 10-30-2025 02-12-2026
Cash flow financing 28.911 M 131.496 M 102.755 M 30.997 M 44.084 M 53.757 M -448.348 M 45.317 M
Other financing cash flows 3.052 M -1.282 M -5.281 M -5.281 M -5.281 M -27.465 M -67.387 M 56.550 M
Cash flow -120.224 M 289.594 M 116.212 M -116.575 M 39.539 M 66.106 M 377.868 M 171.706 M
Net income -65.935 M -16.889 M -111.570 M -83.763 M -57.479 M -66.277 M 251.084 M 186.419 M
Depreciation 13.517 M 15.003 M 13.982 M 14.168 M 14.405 M 13.944 M 13.803 M 13.506 M
Changes in inventories -22.000 K 0.000 0.000 0.000 -6.215 M 0.000 0.000 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -67.620 M 33.940 M -30.250 M -52.910 M 113.769 M -141.381 M 501.107 M -37.166 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 -117.000 K 0.000 0.000 0.000 0.000
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 12.973 M 8.018 M 4.192 M 9.094 M 8.970 M 14.293 M 12.142 M 23.292 M
Cash Change -130.165 M 286.474 M 131.305 M -133.846 M 53.597 M 93.612 M 376.941 M 166.005 M